COLDSTREAM CAPITAL MANAGEMENT INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1082339
BELLEVUE, WA
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,055,385
+$136,354 QoQ
Shares Held
6,151
-5.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#575
of 1,742 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 46%
Shared 0%
None 54%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026COLDSTREAM CAPITAL MANAGEMENT INC holds $14,996,603 across 23 Biotechnology names. VRTX ranks #1 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
6,151 | $3,055,385 | |
| 2 | TECH |
BIO-TECHNE Corp
|
36,070 | $2,548,345 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
3,849 | $927,493 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,384 | $862,979 | |
| 5 | OMER |
Omeros Corp
|
84,743 | $805,905 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
8,635 | $675,861 | |
| 7 | MRNA |
Moderna, Inc.
|
9,260 | $648,477 | |
| 8 | INCY |
Incyte Corp
|
4,536 | $514,200 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,055,385 | 6,151 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,919,031 | 6,537 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,721,066 | 6,002 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,508,845 | 6,406 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,615,104 | 5,874 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,503,125 | 5,163 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,971,619 | 4,896 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,220,291 | 4,774 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $1,978,935 | 4,222 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,659,081 | 3,969 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,599,484 | 3,931 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,286,638 | 3,700 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,271,802 | 3,614 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,126,060 | 3,574 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $971,744 | 3,365 | Shares | Sole | 2023-01-10 | |
| 2022-06-30 | $873,549 | 3,100 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $685,568 | 2,627 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $564,152 | 2,569 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $246,146 | 1,357 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $221,188 | 1,097 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $229,717 | 1,069 | Shares | Sole | 2021-06-16 | |
| 2020-12-31 | $318,822 | 1,349 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $308,584 | 1,134 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $327,759 | 1,129 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $263,886 | 1,109 | Shares | Sole | 2020-05-27 | |
| No filing history on record for this holder in this stock. | ||||||